Independent Evaluation of Reproseq PGS

June 23, 2020

Independent Evaluation of Reproseq PGS

Case Study

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Whether you are expecting or one day hope to be, genetic screening can help empower informed decisions about how to move forward in the future. The goal of PGT-A, as a science, is to identify those embryos with the greatest potential of resulting in healthy outcomes. Mr. Goodman presents his findings in a head to head study performed with Ion Torrent™ ReproSeq™ Assay compared to Illumina™ Veriseq™ Assay. He will discuss the high-resolution sequencing accuracy, data interpretation, and cost effectiveness of the ReproSeq Assay.

Breaking News

The Scan

Not Going With Verily

Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.

From Bread Bakery to Lab Space

The New York Times reports that developers in New York City are increasingly interested in life science spaces.

Decline in Antibodies

A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.

PNAS Papers on Diabetic Kidney Disease, Spontaneous Diploid Yeast Mutations, More

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.

Featured White Papers

Bridging the Efficiency and Throughput Gap with Magnis Automated NGS Library Preparation Solution

Optimized Protocol for Sequencing the SARS-CoV-2 Genome A GenomeWeb eCase Study Transcript

Multiple Focused CRISPR Libraries from a Single Oligo Pool

10 Tips to Scale Your Diagnostics Business & Grow Your Test Portfolio Globally

Oct

28

Featured Webinar

How Low Can You Go? Reduce Breeding Costs with an Optimized Genotyping and Analysis Strategy

Molecular breeding methods such as genomic selection and genome-wide association studies often require high-density genotypic data from many samples, but the cost and complexity of genotyping at this scale may be prohibitive.

Oct

29

Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov

03

Featured Webinar

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

Nov

09

Featured Webinar

The Tumor Neighborhood Watch: How Spatial Architecture and Cellular Neighborhoods Correlate to Colorectal Cancer Outcomes

Most recent single-cell and spatial biology studies have focused on the network of interactions between different cell types and their spatial context.

Menu